Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL2316752

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CC(C)C[C@H](NC(=O)[C@@H](NC(=O)COc1ccc(N(C)C)cc1)C(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)c1nc2ccccc2s1

Basic Information

ChEMBL ID CHEMBL2316752
Phase Preclinical
Structure Type MOL
InChI Key VEMALIBHQMNWOA-GCIMQLSOSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

678.9
MW (Da)
3.31
ALogP
9
HBA
4
HBD
158.8
PSA (Ų)
0.17
QED
1
Ro5 Violations
16
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C35H46N6O6S
MW 678.86
Aromatic Rings 3
Heavy Atoms 48
NP-Likeness -0.66

Activity Summary

IC50 1 meas. best 6.19

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 6.19 6.19 650.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 650.0 nM 6.19 Inhibition of SARS coronavirus 3C-like protease R188I mutant using H-TSAVLQSGFRK... 23245752

Literature References

PubMed DOI Target Context # Activities
23245752 10.1016/j.bmc.2012.11.017 Unchecked 2

Data from ChEMBL 36 via Core Engine